Jaraquemada D, Galocha B, Aparicio P, Rojo S, Calvo V, López de Castro J A
Department of Immunology, Fundación Jiménez Díaz, Madrid, Spain.
Eur J Immunol. 1988 Dec;18(12):1945-50. doi: 10.1002/eji.1830181212.
Cells from the same HLA-B27- individual, PA, were stimulated in vitro in primary mixed lymphocyte culture, with either B2705+ or B2704+ lymphoblastoid cell lines, in independent experiments. Cytolytic T lymphocytes (CTL) were cloned at limiting dilution and the clones obtained were screened for anti-B27 alloreactivity. Most of the CTL clones generated against the B2705+ stimulator cells were directed against the B2705 antigen. In contrast, no anti-B27 CTL clones were found among those derived against the B2704+ stimulator cells. This was not due to a poor cytotoxic response against these cells because a large proportion of the T cell clones derived from this stimulation were cytotoxic. B2704 differs from B2705 by only two amino acid changes at positions 77 and 152. Previous studies (Aparacio, P. et al., Eur. J. Immunol. 1988.18: 203) have shown that none of the anti-B2705 CTL clones derived from donor PA and amenable to detailed characterization cross-reacted with B2704, suggesting that most of this cytotoxic response was directed against an immunodominant determinant contributed for by residues 77 and/or 152 from B2705. The present results further suggest that the changes at these positions in B2704 alter this determinant in such a way that B2704 becomes less immunogenic for the particular individual PA. Furthermore, a similar poor anti-B2704 CTL response was obtained from a second B27- responder individual, AE, stimulated with another B2704+ cell line. The single anti-B2704 CTL clone, 64.8P, isolated from this second individual, displayed an unusual reaction pattern in that it cross-reacted with all B27 subtypes with changes only at or close to positions 77 and 152, including B2705. Significantly, the only HLA-B27 subtype that was not recognized by CTL 64.8P was B2703, which differs from B2705 only at residue 59. This residue is located in the three-dimensional structure at the opposite end from residues 77 and 152 at the surface of the antigen-binding groove of the class I molecule. Thus, the area around residues 77 and 152 is not an essential part of the epitope recognized by CTL 64.8P.
在独立实验中,取自同一HLA - B27阴性个体PA的细胞,在原代混合淋巴细胞培养中,分别与B2705阳性或B2704阳性的淋巴母细胞系进行体外刺激。通过有限稀释法克隆细胞毒性T淋巴细胞(CTL),并对获得的克隆进行抗B27同种异体反应性筛选。针对B2705阳性刺激细胞产生的大多数CTL克隆都针对B2705抗原。相比之下,在针对B2704阳性刺激细胞产生的克隆中未发现抗B27 CTL克隆。这并非由于对这些细胞的细胞毒性反应不佳,因为源自这种刺激的很大一部分T细胞克隆具有细胞毒性。B2704与B2705仅在第77和152位有两个氨基酸差异。先前的研究(Aparacio, P.等人,《欧洲免疫学杂志》1988年。18: 203)表明,从供体PA获得的、适合详细表征的抗B2705 CTL克隆中,没有一个与B2704发生交叉反应,这表明这种细胞毒性反应的大部分是针对由B2705的第77和/或152位残基贡献的免疫显性决定簇。目前的结果进一步表明,B2704中这些位置的变化改变了这个决定簇,使得B2704对特定个体PA的免疫原性降低。此外,在用另一个B2704阳性细胞系刺激的第二个B27阴性反应个体AE中,也获得了类似的针对B2704的CTL反应不佳的结果。从第二个个体中分离出的单个抗B2704 CTL克隆64.8P,表现出一种不寻常的反应模式,即它与所有仅在第77位或接近第77位以及第152位有变化的B27亚型发生交叉反应,包括B2705。值得注意的是,CTL 64.8P唯一未识别的HLA - B27亚型是B2703,它与B2705仅在第59位残基不同。该残基位于I类分子抗原结合槽表面与第77和152位残基相对的三维结构末端。因此,第77和152位残基周围的区域不是CTL 64.8P识别的表位的必要组成部分。